#blenrep - Twitter Hashtag

8 months ago

Great analogy of a guided Missile Myeloma Treatment from @EricWolf_USMC part of the #IMFASH25 Myeloma Voices Team. #myeloma #mmsm #blenrep #ASH25

Eric S Wolf @EricWolf_USMC

8 months ago

Guided Missile Myeloma Treatment: Blenrep

1

6

5

1

787

0

6

1

2

418

Teresa Miceli. ❤️&☮️4🌎 @IMFnurseMyeloma

9 months ago

Reports like this & continues studies have resulted in #Bela being back! #Blenrep FDA approved for #RRMM. More to come at #ASH25 #mmsm #myeloma @IMFMyeloma #IMFASH25

Robin Tuohy @IMFsupport

over 1 year ago

Abstract 497: Phase 1 Bela in combo with SOC transplant ineligible NDMM-Dreamm-9 Updated Interim Analysis ⁦@szusmani⁩ ⁦@TerryGlassman⁩ #ASH24 #IMFASH24 #MMsm

0

10

9

0

1K

1

8

1

0

772

Mustafa Özdoğan, MD

@ozdogan_md

9 months ago

FDA Approval Alert! Belantamab mafodotin returns stronger than ever — a BCMA ADC redefining survival in relapsed myeloma. 31 mo PFS, OS HR 0.49 — DREAMM-7 sets a new benchmark. #FDAapproval #MultipleMyeloma #Blenrep #Oncology #Hematology #ADC #CancerResearch #DREAMM7 #PrecisionOncology

ozdogan_md's tweet photo. FDA Approval Alert!

Belantamab mafodotin returns stronger than ever — a BCMA ADC redefining survival in relapsed myeloma.

31 mo PFS, OS HR 0.49 — DREAMM-7 sets a new benchmark.

#FDAapproval #MultipleMyeloma #Blenrep #Oncology #Hematology #ADC #CancerResearch #DREAMM7 #PrecisionOncology

1

13

5

2

1K

Beth Faiman PhD

@Bethfaiman

9 months ago

@domenica76 But #blenrep is not approved with Pom…. Any thoughts why @JoshuaRichterMD @RahulBanerjeeMD ??

1

3

1

674

Blood Cancer UK @bloodcancer_uk

10 months ago

Big news for people with #myeloma in Scotland! #Blenrep (belantamab mafodotin) has been approved by the SMC for NHS use with BorDex at 2nd -line when lenalidomide is unsuitable. England ✅ Scotland ✅ Still waiting on Northern Ireland. We’ll keep pushing for equal access.

bloodcancer_uk's tweet photo. Big news for people with #myeloma in Scotland!

#Blenrep (belantamab mafodotin) has been approved by the SMC for NHS use with BorDex at 2nd -line when lenalidomide is unsuitable.

England ✅ Scotland ✅

Still waiting on Northern Ireland.

We’ll keep pushing for equal access. https://t.co/KPt9cKAgwu

0

16

4

0

2K

Multiple Myeloma RF @theMMRF

about 1 year ago

Blenrep has been approved in both the EU 🇪🇺 and Canada 🇨🇦—a meaningful step toward broader global access for myeloma patients. In the U.S., the FDA review continues. Here’s what patients should know: https://t.co/GXppipRQXj  #MultipleMyeloma #Blenrep #MMRF

0

6

3

0

926

Myeloma Patients Europe @MyelomaEurope

about 1 year ago

BREAKING NEWS: EU approves belantamab mafodotin (Blenrep®) combinations for relapsed/refractory #myeloma patients! Two new treatment options approved based on positive DREAMM-7 & DREAMM-8 trials showing extended progression-free survival. https://t.co/j42l7j0OcA #Blenrep

0

6

3

0

456

HemOnc Today @HemOncToday

about 1 year ago

An #FDA advisory committee ruled against two different #Blenrep combos for #MultipleMyeloma. 📝 Despite the decisions, @RahulBanerjeeMD of @fredhutch @UW remains “cautiously optimistic” due to PFS benefit in phase 3 trials. Read more👇 https://t.co/X6Yk1ayI7v

HemOncToday's tweet photo. An #FDA advisory committee ruled against two different #Blenrep combos for #MultipleMyeloma.

📝 Despite the decisions, @RahulBanerjeeMD of @fredhutch @UW remains “cautiously optimistic” due to PFS benefit in phase 3 trials.

Read more👇
https://t.co/X6Yk1ayI7v https://t.co/zVGng0at65

0

5

2

836

Multiple Myeloma RF @theMMRF

about 1 year ago

The FDA has delayed its decision on Blenrep. The MMRF remains hopeful and continues to support approval. Blenrep offers real potential for patients who need accessible, effective care. Learn more: https://t.co/GXppipRj7L #MultipleMyeloma #Blenrep #MMRF #FDA

0

4

0

687

Multiple Myeloma RF @theMMRF

about 1 year ago

The MMRF weighs in on the latest Blenrep (belantamab mafodotin) news and what it means for patients. With the FDA's decision pending, we’re closely watching next steps. Stay informed and read more 👉 https://t.co/EiICoGimBz #MultipleMyeloma #Blenrep

0

7

4

0

886

ET NOW

@ETNOWlive

about 1 year ago

#MarketAlert | #European markets end mixed; GSK tumbles 4% after FDA panel rejects cancer drug Blenrep #StockMarket #GSK #EuropeMarkets #StockMarket #GSK #EuropeMarkets #DAX #FTSE100 #CAC40 #HealthcareStocks #TechStocks #FDA #Blenrep #Investing #MarketUpdate #Pharma

ETNOWlive's tweet photo. #MarketAlert | #European markets end mixed; GSK tumbles 4% after FDA panel rejects cancer drug Blenrep

#StockMarket #GSK #EuropeMarkets #StockMarket #GSK #EuropeMarkets #DAX #FTSE100 #CAC40 #HealthcareStocks #TechStocks #FDA #Blenrep #Investing #MarketUpdate #Pharma https://t.co/rDj270Xgtf

2

9

2

0

3K

HemOnc Today @HemOncToday

about 1 year ago

🚫 'Surprising' setback for #Blenrep as #FDA panel turns down 2 different combos for relapsed/refractory #MultipleMyeloma. The hold-up? Reversible ocular toxicity at the “proposed doses” 👀 https://t.co/ik6CjDWWF9

0

5

2

0

617

Multiple Myeloma RF @theMMRF

about 1 year ago

The FDA’s ODAC voted against the current benefit-risk profile of #Blenrep. Approval of this novel therapy is still pending. The MMRF continues to champion safety, equitable access, shared decision-making & team-based care in the development of new #myeloma therapies.

0

4

1

0

988

Sarah Clark @SarahClarkBDM

over 1 year ago

Great to see GSK’s Blenrep making a comeback. After being pulled from the U.S. market, its U.K. approval shows the evolving regulatory and clinical landscape for blood cancer therapies. Hoping this means more options soon for patients in need. #healthcare #oncology #Blenrep

MailMyStatements 🛡📬

@MailMyStatement

over 1 year ago

GSK blood cancer therapy, once pulled from the market, is approved in the U.K. https://t.co/SZQq1L1dFw via @statnews #healthcare

0

2

0

102

0

2

0

94

Comunidad Española Pacientes con Mieloma Múltiple.

@Cemmp_mieloma

over 1 year ago

Reino Unido otorga primera aprobación para #Blenrep en #MielomaMúltiple para su uso en terapias combinadas para tratar adultos con #mieloma que han recibido al menos una terapia previa. Noticia de @Investingcom 👇 https://t.co/FilqwoT3W1

0

10

2

1

248

ipharmacenter @ipharmacenter

over 1 year ago

#Blenrep Shows Notable Survival Advantage, Cutting Death Risk by 42% in Relapsed #MultipleMyeloma https://t.co/TexJ6XxXxL #pharma #pharmaceutical #Science #TeleMedicine #news #media #medicine #VTP #VTP2025 #Hematologia #MedicinaGlobal #ASH24 #ASHaiku #ASH25 #hematology

0

87

ipharmacenter @ipharmacenter

over 1 year ago

#Blenrep Shows Notable Survival Advantage, Cutting Death Risk by 42% in Relapsed #MultipleMyeloma https://t.co/6ldhpozJSK #pharma #pharmaceutical #Science #TeleMedicine #news #media #medicine #ASH2024 #ASH24 #hematology #breaking #breakingnews #GSK #GSKNews

0

159

ipharmacenter @ipharmacenter

about 2 years ago

#GSKNews - #Blenrep Combination Significantly Lowers Disease Progression or #Death Risk by Nearly 50% in Relapsed/Refractory #MultipleMyeloma https://t.co/kZ2d5S8VXl #ASCO24 #ASCO2024 #Science #MedComms #healthcare #MedicalAffairs #news #media #breaking #OncoAlert

$ipharmacenter's tweet photo. #GSKNews - #Blenrep Combination Significantly Lowers Disease Progression or #Death Risk by Nearly 50% in Relapsed/Refractory #MultipleMyeloma https://t.co/kZ2d5S8VXl #ASCO24 #ASCO2024 #Science #MedComms #healthcare #MedicalAffairs #news #media #breaking #OncoAlert https://t.co/vDwAuiSVq8$

0

1

0

195

Pharmafocus @Pharmafocus

over 2 years ago

GSK shares results from phase 3 trial for Blenrep for treatment of multiple myeloma https://t.co/TI11AnpGtT #Blenrep #clinicaltrial #GSK

0

4

0

786

HealthTree Foundation

@HealthTree

over 2 years ago

#Blenrep (belantamab mafodotin) is an anti-BCMA therapy proving its efficacy in clinical trials when compared to standard of care for #myeloma treatment. Learn more about Blenrep and the results of the DREAMM-7 Phase III Clinical Trial here: https://t.co/vf1BH1rVeE #mmsm

HealthTree's tweet photo. #Blenrep (belantamab mafodotin) is an anti-BCMA therapy proving its efficacy in clinical trials when compared to standard of care for #myeloma treatment. Learn more about Blenrep and the results of the DREAMM-7 Phase III Clinical Trial here: https://t.co/vf1BH1rVeE

#mmsm https://t.co/HV2EFTOGlD

0

3

1

683

Top Tweets for #blenrep

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users